Actively Recruiting
Evaluating the Safety and Early Effects of Aleeto in Treating Multiple System Atrophy Parkinsonian Type in Adults Aged 30 to 75
Led by Beijing Tiantan Hospital · Updated on 2025-09-03
20
Participants Needed
1
Research Sites
13 weeks
Total Duration
AI-Summary
What This Trial Is About
This research investigates multiple system atrophy MSA, a rare and progressive neurodegenerative disorder that affects autonomic functions, movement, and coordination. MSA primarily impacts adults with an average onset age around 56 years and leads to severe disability within a few years. The study aims to evaluate the safety, tolerability, and early signs of effectiveness of Aleeto, a nerve repair protein derived from stem cell exosomes, in patients with MSA-parkinsonian type MSA-P. Participants are randomly assigned to either receive Aleeto through a combination of intrathecal and intravenous administrations or to a control group receiving standard basic treatment without trial-related medication. Aleeto is given intrathecally on days 1, 31, and 61, and intravenously once daily during specific periods. After an initial 90-day treatment and follow-up phase, all participants may choose to continue Aleeto in an open-label extension phase with three additional intravenous treatment periods. During the study, participants undergo comprehensive assessments including vital signs, neurological exams, laboratory tests, imaging such as MRI and bladder ultrasound, and multiple neurological and quality-of-life scales. Cerebrospinal fluid is also collected at various stages. Researchers closely monitor safety through adverse event reporting and evaluate changes in motor symptoms and autonomic function. Follow-up visits continue up to one year after randomization to assess ongoing effects and safety.
CONDITIONS
Brief Title
The Study of Safety and Preliminary Efficacy of Aleeto in Patients With MultIple System Atrophy
Research Team
W
Weiqi Chen, M.D.
L
Lei Guo
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here